NLRP3 and Hyperglycemia: GLP-1 RAs can additionally guard against hyperglycaemia-induced autoinflammatory damage, inhibiting NLR family pyrin domain-containing 3 (NLRP3) inflammasome formation and thereby conferring anti-pyroptotic effects on cardiomyocytes [133].